Epirus Biopharmaceuticals - Dividend History | EPRSQ
Historical dividend payout and yield for Epirus Biopharmaceuticals (EPRSQ) since 1971. The current TTM dividend payout for Epirus Biopharmaceuticals (EPRSQ) as of December 31, 1969 is $0.00. The current dividend yield for Epirus Biopharmaceuticals as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
EPIRUS Biopharmaceuticals Inc. is a biopharmaceutical company. It is focused on the development and commercialization of biosimilar monoclonal antibodies. Its products include BOW015, a monoclonal antibody against tumor necrosis factor alpha, used to treat autoimmune diseases. EPIRUS Biopharmaceuticals Inc., formerly known as Zalicus Inc., is based in Boston, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
